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background: Pulmonary hypertension (PH), and in particular, mixed PH, has a negative effect on heart failure (HF) survival. The relationship 
between mixed PH and outcomes in patients undergoing continuous-flow left ventricular assist device (CF-LVAD) implantation is unknown.
Methods: We retrospectively reviewed patients implanted with a CF-LVAD at our center between 2005-2013. We excluded patients undergoing 
LVAD exchange and those without complete hemodynamic data. Mixed PH was defined as pulmonary vascular resistance (PVR) ≥ 3 WU. Cox 
regression was used to model HF hospitalization-free survival.
results: 203 patients were included with a median follow up of one year (77% male, mean age 60, 81% destination therapy). 39% of patients had 
mixed PH (mean PVR 4.5 ± 1.3 WU). Patients with mixed PH had lower cardiac output, higher bilirubin and higher Model for End-Stage Liver Disease 
score (Table). Post-LVAD right ventricular failure occurred with similar frequency in both groups (32% v. 31%; p=0.9). 39% of patients suffered a HF 
hospitalization or death. Mixed PH was not associated with time to HF hospitalization or death (Hazard Ratio [HR] 0.9 [0.6-1.3]; p=0.9) or time to 
either component of the primary outcome (HR 0.8 [0.5-1.3]; p = 0.4 for HF hospitalization; HR 0.9 [0.6-1.5], p = 0.7 for death).
conclusion: Patients with mixed PH undergoing CF-LVAD implantation have increased HF severity, but similar rates of right ventricular failure, HF 
hospitalization and survival compared to patients without mixed PH. 
Characteristic PVR>3 (n=124) PVR <3 (n=79) P
Male - no. (%) 56 (71) 101 (82) 0.08
Age (yr) 62 +/- 12 58.5 +/- 14 0.1
CVP (mmHg) 12 +/- 5 11 +/- 6 0.23
MPAP (mmHg) 40 +/- 7 32 +/- 9 <0.001
CO (l/min) 3.8 +/- 0.9 5 +/- 1.7 <0.001
SVR (dyn.s/cm5) 1520 +/- 447 1180 +/- 404 <0.001
bilirubin (mg/dL) 1.3 +/- 1.2 0.9 +/- 0.6 <0.01
MELD score 11.8 +/- 5 10.1 +/- 5 0.02
PVR - pulmonary vascular resistance
CVP - central venous pressure
MPAP - mean pulmonary arterial pressure
CO - cardiac output
SVR - systemic vascular resistance
MELD - model for end-stage liver disease
